We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$90.2M
AUM Growth
-$6.75M
(-7%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-15.42%
Top 10 Holdings %
Top 10 Hldgs %
39%
Holding
124
New
12
Increased
17
Reduced
57
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$926K |
| 2 |
Pentair
PNR
|
+$778K |
| 3 |
Plus Therapeutics
PSTV
|
+$606K |
| 4 |
Veritone
VERI
|
+$556K |
| 5 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$2.06M |
| 2 |
Tactile Systems Technology
TCMD
|
+$1.84M |
| 3 |
NeoGenomics
NEO
|
+$1.68M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.68M |
| 5 |
Ooma
OOMA
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.72% |
| 2 | Industrials | 11.67% |
| 3 | Technology | 9.76% |
| 4 | Financials | 3.3% |
| 5 | Communication Services | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEMI
76
DELISTED
Chembio diagnostics, Inc.
CEMI
| $281K | 0.31% |
46,450
-3,000
| -6% | -$18.7K |
|
|
SRCI
77
DELISTED
SRC Energy Inc
SRCI
| $269K | 0.3% |
40,000
| – | – |
|
78
XPO
XPO
$24.4B
| $248K | 0.28% |
+11,080
| New | +$207K |
|
|
CTG
79
DELISTED
Computer Task Group, Inc.
CTG
| $245K | 0.27% |
+43,800
| New | +$246K |
|
80
Quest Diagnostics
DGX
$25.6B
| $228K | 0.25% |
2,050
| – | – |
|
81
Intel
INTC
$462B
| $218K | 0.24% |
6,450
-150
| -2% | -$5.37K |
|
82
Baxter International
BAX
$12.1B
| $212K | 0.24% |
3,500
-400
| -10% | -$22.7K |
|
|
BREW
83
DELISTED
Craft Brew Alliance, Inc.
BREW
| $211K | 0.23% |
12,550
+100
| +0.8% | +$1.54K |
|
84
General Mills
GIS
$19.5B
| $203K | 0.23% |
3,656
-400
| -10% | -$22.8K |
|
|
ARC
85
DELISTED
ARC Document Solutions, Inc.
ARC
| $201K | 0.22% |
48,416
+5,000
| +12% | +$18.6K |
|
|
CASC
86
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $194K | 0.22% |
52,129
+4,000
| +8% | +$15.9K |
|
87
Option Care Health
OPCH
$3.42B
| $191K | 0.21% |
17,625
-60,000
| -77% | -$456K |
|
|
AMRN
88
Amarin Corp
AMRN
$290M
| $167K | 0.19% |
2,075
+350
| +20% | +$21.8K |
|
89
Codexis
CDXS
$141M
| $164K | 0.18% |
+30,000
| New | +$138K |
|
90
Altimmune
ALT
$576M
| $163K | 0.18% |
1,697
-36
| -2% | -$5.98K |
|
91
Riot Platforms
RIOT
$8.31B
| $145K | 0.16% |
35,586
-5,075
| -12% | -$19.5K |
|
|
MMAT
92
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $129K | 0.14% |
388
| – | – |
|
93
LiqTech
LIQT
$22.4M
| $115K | 0.13% |
11,183
-4,090
| -27% | -$45.9K |
|
|
OTRK
94
DELISTED
Ontrak
OTRK
| $113K | 0.13% |
+274
| New | +$107K |
|
95
Nuwellis
NUWE
$183K
| – | – |
0
| – | – |
|
96
Nortech Systems
NSYS
$42M
| $102K | 0.11% |
28,500
| – | – |
|
|
DXTR
97
DELISTED
Dextera Surgical Inc.
DXTR
| $100K | 0.11% |
+333,983
| New | +$169K |
|
|
DGLT
98
DELISTED
Digiliti Money Group, Inc. Common Stock
DGLT
| $88K | 0.1% |
+27,778
| New | +$103K |
|
|
ELGX
99
DELISTED
Endologix Inc
ELGX
| $49K | 0.05% |
1,010
-170
| -14% | -$10K |
|
|
PLM
100
DELISTED
PolyMet Mining Corp.
PLM
| $42K | 0.05% |
7,113
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Perkins Capital Management held 124 positions worth $90.2M, down 7% from $96.9M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management withdrew a net $13.9M in Q2 2017, closing 18 positions and reducing 57 holdings. Its most notable exit was Tactile Systems Technology, an estimated $1.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 58% a quarter earlier, followed by Industrials and Technology.
Against the trend, Perkins Capital Management opened a new position in Cencora worth $983K.
- Perkins Capital Management's largest Q2 2017 buy was Cencora: 10,400 shares worth $983K.
- Perkins Capital Management added most to Plus Therapeutics in Q2 2017, an estimated $606K increase.
- Perkins Capital Management's biggest Q2 2017 reduction was Cardiovascular Systems, Inc., cutting an estimated $2.06M.
- Perkins Capital Management fully exited Tactile Systems Technology in Q2 2017, selling an estimated $1.84M.
- Perkins Capital Management's ten largest holdings make up 39% of its $90.2M portfolio in Q2 2017.
- Perkins Capital Management opened 12 new positions and closed 18 in Q2 2017.
- Perkins Capital Management's portfolio value fell 7% quarter-over-quarter to $90.2M.
Based on Perkins Capital Management's 13F filing for Q2 2017, filed 26 Jul 2017.